Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK-wide real-world cohort of relapsed myeloma patients.
Br J Haematol
; 201(1): 162-167, 2023 04.
Article
in En
| MEDLINE
| ID: mdl-36720464
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Frailty
/
Multiple Myeloma
Type of study:
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Br J Haematol
Year:
2023
Document type:
Article
Affiliation country:
Reino Unido